XML 56 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1

Segment Information (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment

		2018				2017				2016
Net sales
Oral, Personal and Home Care
North America(1)		$	3,348			$	3,117			$	3,183
Latin America		3,605				3,887				3,650
Europe		2,502				2,394				2,342
Asia Pacific		2,734				2,781				2,796
Africa/Eurasia		967				983				960
Total Oral, Personal and Home Care		13,156				13,162				12,931
Pet Nutrition(2)		2,388				2,292				2,264
Total Net sales		$	15,544			$	15,454			$	15,195

_________

⁽¹⁾    Net sales in the U.S. for Oral, Personal and Home Care were $3,091, $2,865 and $2,932 in 2018, 2017 and 2016, respectively.

⁽²⁾    Net sales in the U.S. for Pet Nutrition were $1,304, $1,246 and $1,243 in 2018, 2017 and 2016, respectively.

		2018				2017				2016
Operating profit
Oral, Personal and Home Care
North America		$	1,037			$	1,043			$	1,087
Latin America		995				1,171				1,139
Europe		634				605				586
Asia Pacific		777				842				888
Africa/Eurasia		173				180				187
Total Oral, Personal and Home Care		3,616				3,841				3,887
Pet Nutrition		680				677				677
Corporate		(602		)		(811		)		(609		)
Total Operating profit		$	3,694			$	3,707			$	3,955

		2018				2017				2016
Capital expenditures
Oral, Personal and Home Care
North America		$	53			$	74			$	151
Latin America		131				127				94
Europe		39				63				51
Asia Pacific		75				125				120
Africa/Eurasia		11				13				17
Total Oral, Personal and Home Care		309				402				433
Pet Nutrition		35				33				38
Corporate		92				118				122
Total Capital expenditures		$	436			$	553			$	593

		2018				2017				2016
Depreciation and amortization
Oral, Personal and Home Care
North America		$	88			$	58			$	54
Latin America		82				82				76
Europe		70				74				64
Asia Pacific		103				101				96
Africa/Eurasia		8				8				7
Total Oral, Personal and Home Care		351				323				297
Pet Nutrition		53				53				53
Corporate		107				99				93
Total Depreciation and amortization		$	511			$	475			$	443

		2018				2017				2016
Identifiable assets
Oral, Personal and Home Care
North America		$	3,310			$	2,608			$	2,685
Latin America		2,225				2,423				2,314
Europe		2,883				3,781				3,554
Asia Pacific		2,148				2,244				2,006
Africa/Eurasia		502				544				499
Total Oral, Personal and Home Care		11,068				11,600				11,058
Pet Nutrition		1,033				1,026				1,009
Corporate(1)		60				50				56
Total Identifiable assets(2)		$	12,161			$	12,676			$	12,123

____________

⁽¹⁾  In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). In 2017, Corporate identifiable assets primarily consist of derivative instruments (5%) and investments in equity securities (86%). In 2016, Corporate identifiable assets primarily consist of derivative instruments (24%) and investments in equity securities (68%). 

⁽²⁾  Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-half of total long-lived assets of $8,259 in 2018 and one-third of total long-lived assets of $7,908 and $7,642 in 2017 and 2016, respectively.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration